Myotonic dystrophy type 1 (DM1) results from an expanded non-coding CTG repeat in the DMPK gene, leading to splicing issues due to the sequestration of the splicing regulator MBNL1.
In a DM1 model cell line, an increase in CUG repeat RNA was found to significantly decrease MBNL1 protein levels without affecting its mRNA, pointing to a possible degradation mechanism.
Proteasome inhibitors helped recover some MBNL1 protein expression, indicating that CUG repeats might lead to MBNL1 degradation via a polyubiquitin-independent pathway, which contributes to the disease's effects.